IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Ther a peu tic Classes (% of Sales by Lead ing
5): 90-95%
Dose Forms (% of Sales by Lead ing 5): n.a.
Prin ci pal Prod ucts:
METOPROLOL SANDOZ (beta-blocker agent
plain)
RISPERIDON SDZ (antipsychotic)
RAMIPRIL SANDOZ (ACE in hib i tor plain)
PRAVASTATIN SANDOZ (cho les terol/triglyceride
reg u lat ing prep a ra tion)
LORATADIN SANDOZ (an ti his ta mine sys temic)
Ther a peu tic Range:
beta-block ing agents 51%
psycholeptics 16%
renin-an gio ten sin sys tem agents 12%
lipid-reg u lat ing/antiatheroma prep a ra tions 8%
an ti his ta mines sys temic 5%
Lead ing Dose Forms:
tab lets 83%
coated tab lets 17%
cap sules -
PAKISTAN
NOVARTIS
Full Name: Novartis Pharma Pa ki stan Ltd
Street Ad dress: 15 West Wharf, Karachi 74000
Tel: +92 21 2313386-90
Fax: +92 21 2310072/2311009
Home Page: www.novartis.com
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, im porter, ex porter, dis -
trib u tor, pro moter, sales/detailer. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion, non-pre scrip tion), hos pi tal
pharmaceuticals, bio tech nol ogy prod ucts, di -
etetic/nu tri tional prod ucts, oph thal mic prod ucts.
Es tab lished 1963. 637 phar ma ceu ti cal em ploy ees
in 2007. Di vi sions in clude: Pharma; Consumer
Health; Sandoz (Generic).
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 230 (2007)
Con tacts (Pharm): Chair man: Dr Farid Khan;
Com mer cial Op er a tions: Farhaw Malik, M. Aslam,
Shamsul Is lam, Sabir Khan Afridi, Rehmat Ullaha;
Man u fac ture: Khalid Yousuf; Gen eral Con tact: Dr
Farid Khan
Sub sid iary of: Novartis, Swit zer land (98%)
Phar ma ceu ti cal Sales: US$ 30-35 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
VOLTRAL (antirheumatic non-steroidal)
TEGRAL (antiepileptic)
CAFLAM (antirheumatic non-steroidal)
SYNTOCINON (la bor in ducer)
MEPRESOR (beta-blocker agent plain)
Ther a peu tic Range:
anti rheu ma tics sys temic 26%
antiepileptics 11%
gynecologicals other 10%
ap pe tite stim u lants 8%
renin-an gio ten sin sys tem agents 6%
Lead ing Dose Forms:
tab lets 38%
coated tab lets 31%
am poules 11%
liq uids 10%
cap sules 8%
NOVARTIS CON SUMER HEALTH
Postal Ad dress: PO Box 100, Karachi 74000
Street Ad dress: 15 West Wharf, Karachi 74000
Tel: +92 21 2313386/87/88/89/90
Fax: +92 21 2310027
Home Page: www.pk.novartis.com
De scrip tion: De vel oper, man u fac turer, ex -
porter, dis trib u tor, pro moter, sales/detailer. Prod -
uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion). Es tab lished 2001. 280
phar ma ceu ti cal employees in 2005.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2005)
Con tacts (Pharm): Chair man: Malik
Farhanbedar; Com mer cial Op er a tions: Naseer Zia
Phar ma ceu ti cal Sales: US$ 22-24 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
CAC 1000 (cal cium prod uct)
SANCOS CO (antitussive)
OPTALIDON (an al ge sic non-nar cotic)
CAC 1000 PLUS (cal cium prod uct)
TANDEGYL (an ti his ta mine sys temic)
Ther a peu tic Range:
min eral sup ple ments 53%
cough and cold prep a ra tions 14%
an al ge sics 10%
© 2009 IMS Health In cor po rated or its af fil i ates Page 193